Atria Investments Inc Has $822,000 Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Atria Investments Inc boosted its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 43.9% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,853 shares of the medical instruments supplier’s stock after purchasing an additional 2,701 shares during the period. Atria Investments Inc’s holdings in LeMaitre Vascular were worth $822,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the company. NBC Securities Inc. increased its stake in shares of LeMaitre Vascular by 73.2% in the third quarter. NBC Securities Inc. now owns 433 shares of the medical instruments supplier’s stock valued at $40,000 after buying an additional 183 shares during the period. GAMMA Investing LLC boosted its position in LeMaitre Vascular by 57.0% during the 2nd quarter. GAMMA Investing LLC now owns 548 shares of the medical instruments supplier’s stock worth $45,000 after buying an additional 199 shares during the period. USA Financial Formulas bought a new stake in LeMaitre Vascular during the 3rd quarter worth approximately $60,000. West Oak Capital LLC acquired a new position in LeMaitre Vascular in the 2nd quarter valued at approximately $58,000. Finally, nVerses Capital LLC increased its position in LeMaitre Vascular by 33.3% in the 2nd quarter. nVerses Capital LLC now owns 800 shares of the medical instruments supplier’s stock valued at $66,000 after acquiring an additional 200 shares during the period. 84.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently commented on LMAT. Cantor Fitzgerald initiated coverage on shares of LeMaitre Vascular in a report on Tuesday, October 15th. They set a “neutral” rating and a $96.00 price target on the stock. Lake Street Capital started coverage on LeMaitre Vascular in a research report on Friday, August 2nd. They issued a “buy” rating and a $105.00 price target on the stock. StockNews.com raised LeMaitre Vascular from a “hold” rating to a “buy” rating in a research note on Wednesday, November 6th. Oppenheimer reaffirmed an “outperform” rating and issued a $93.00 price objective (up from $90.00) on shares of LeMaitre Vascular in a research note on Friday, November 1st. Finally, JMP Securities upped their target price on LeMaitre Vascular from $77.00 to $100.00 and gave the company a “market outperform” rating in a report on Tuesday, August 20th. Two research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, LeMaitre Vascular has an average rating of “Moderate Buy” and a consensus price target of $94.57.

LeMaitre Vascular Price Performance

Shares of LeMaitre Vascular stock opened at $103.55 on Tuesday. The stock’s 50-day moving average is $92.11 and its 200 day moving average is $85.89. LeMaitre Vascular, Inc. has a one year low of $51.70 and a one year high of $106.49. The firm has a market cap of $2.33 billion, a price-to-earnings ratio of 56.04, a PEG ratio of 2.50 and a beta of 0.89.

LeMaitre Vascular (NASDAQ:LMAT) last posted its quarterly earnings results on Thursday, October 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.44 by $0.05. The firm had revenue of $54.82 million for the quarter, compared to analysts’ expectations of $53.50 million. LeMaitre Vascular had a return on equity of 13.15% and a net margin of 19.40%. The company’s revenue for the quarter was up 15.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.33 EPS. On average, sell-side analysts expect that LeMaitre Vascular, Inc. will post 1.94 EPS for the current fiscal year.

LeMaitre Vascular Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 5th. Shareholders of record on Thursday, November 21st will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.62%. The ex-dividend date is Thursday, November 21st. LeMaitre Vascular’s payout ratio is 34.97%.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.